Answers are grounded in this paper and cite their sources.
People living with SZ or BD-I cited a range of favourable and unfavourable experiences with oral antipsychotic medications. Most participants reported that their antipsychotics were effective at controlling their symptoms, but multiple side effects impacted their quality of life, caused additional serious health problems, and often led to discontinuation of or switching antipsychotics. Findings from this study contribute to a better understanding of patients' experiences with antipsychotics and highlight a need for new medications with favourable benefit/risk profiles.
No takes yet. Share an insight, caveat, or question.
Doane et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: